Senior Medical Director, Global Rare

Overview 

The Medical Senior Director Global Rare, reporting into the VP, Medical Affairs Head Global Rare, will be responsible for building and for developing strategies and tactical execution plans in the Rare TAs at Alnylam. He/she will be the key driver of activities to engage health care professionals, and medical organizations. The Senior Medical Director will be well-versed in clinical practice and clinical research so as to deliver cutting edge data and technical/practical education to Health Care Professionals. 

He/she will provide strategic and operational support for executing Medical Affairs goals and objectives. This position will involve cultivating professional relationships as well as oversight and health outcomes initiatives at a global level. The strategic areas of focus include: investigator sponsored studies, health-care and payer decision maker education, and company sponsored clinical trial recruitment.

Key Responsibilities

• Lead, communicate and execute the development of an integrated medical affairs plan. Foster the establishment and maintenance of key external thought leaders through gaining knowledge on their insights and development of scientific/clinical engagement plans.
• Implement strategies to accelerate company sponsored and investigator sponsored studies.
• Provide medical leadership for scientific review and approval of communication materials and medical materials in compliance with corporate standards and government/industry regulations.
• Represent Alnylam at medical meetings, conferences, advisory boards, outreach meetings at key institutions, and in interactions with thought leaders.
• Facilitate global advisory boards to gain insights for the development of innovative approaches in the specific TAs.
• Provide Medical Affairs support to review requests for grants and sponsorships. Ensure that review and approval processes strictly follow compliance guidelines.
• Manage and develop Medical Directors including hiring, training, evaluation and motivation, in alignment with Alnylam’s corporate values, strategies and objectives.
• Develop and maintain productive and appropriate relationships with individuals across the organization including cross-functional groups.
• Collaborate closely with Preclinical, Regulatory, Clinical Operations, Biometrics, Medical Affairs and Commercial to ensure tight strategic integration of product development plans.
• Accountable for progress of projects within his/her sphere of accountability, across disease areas.

Qualifications

A highly driven, dynamic, engaged and accomplished Clinical Development physician with late stage development experience and leadership experience. The individual must be strategic with affective communication skills. The ideal candidate will be a highly innovative, collaborative, scientifically grounded and an accomplished Medical Affairs physician with a flexible, hands-on and team oriented style be relationship oriented and have an entrepreneurial spirit. 

Specific qualifications include:

• MD with 10+ years of Clinical Development and/or Medical Affairs experience. Previous experience in rare disease therapeutic area is preferred.
• Excellent communication, presentation and time management skills required; must be adaptable and able to work well within a team and relate effectively with people at all levels of the organization.
• Able to inspire a team to excel by fostering a climate of energy, excitement and personal accountability.
• Current working knowledge of legal, regulatory, and compliance regulations and guidelines.
• Ability to partner with key internal stakeholders.

Overnight business travel of up to 50% is required.
 

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.